IRIS
FLAMMINI, Lisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.106
AS - Asia 3.218
EU - Europa 2.587
SA - Sud America 368
AF - Africa 209
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 11.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.987
SG - Singapore 1.096
CN - Cina 935
IT - Italia 535
VN - Vietnam 534
FI - Finlandia 416
IE - Irlanda 382
SE - Svezia 363
BR - Brasile 276
DE - Germania 248
HK - Hong Kong 228
ZA - Sudafrica 130
FR - Francia 126
UA - Ucraina 117
NL - Olanda 115
TR - Turchia 97
GB - Regno Unito 82
IN - India 79
CA - Canada 69
RU - Federazione Russa 51
BD - Bangladesh 49
CI - Costa d'Avorio 39
AR - Argentina 35
BE - Belgio 31
ES - Italia 25
MX - Messico 25
JP - Giappone 24
PL - Polonia 24
KR - Corea 21
ID - Indonesia 20
CZ - Repubblica Ceca 17
PK - Pakistan 17
IQ - Iraq 16
PH - Filippine 14
AT - Austria 13
EC - Ecuador 13
CO - Colombia 10
PY - Paraguay 9
RO - Romania 9
TH - Thailandia 9
TW - Taiwan 9
UZ - Uzbekistan 8
VE - Venezuela 8
CH - Svizzera 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
MY - Malesia 7
NP - Nepal 7
SA - Arabia Saudita 7
BO - Bolivia 6
PA - Panama 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EU - Europa 5
MA - Marocco 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
ET - Etiopia 4
IR - Iran 4
AL - Albania 3
JM - Giamaica 3
KZ - Kazakistan 3
LT - Lituania 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
SC - Seychelles 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MC - Monaco 1
Totale 11.488
Salva come PNG Salva come JPEG
Città #
Dallas 1.564
Singapore 617
Ashburn 492
Chandler 398
Dublin 381
San Jose 333
Santa Clara 244
Beijing 233
Ann Arbor 222
Hong Kong 210
Parma 207
Ho Chi Minh City 164
Dearborn 149
Jacksonville 145
Johannesburg 127
Boardman 119
Hanoi 108
New York 108
Shanghai 85
Munich 84
Nanjing 78
Los Angeles 76
Izmir 74
Princeton 60
Lauterbourg 58
Hefei 52
Wilmington 40
Abidjan 39
Chicago 39
Milan 39
Bremen 35
Buffalo 33
Groningen 33
Toronto 33
Helsinki 32
Brussels 30
San Mateo 29
Bangalore 27
Council Bluffs 27
Kunming 26
Des Moines 25
São Paulo 25
Guangzhou 23
Moscow 23
Haiphong 22
Hebei 22
Jinan 22
Columbus 21
Da Nang 21
Bologna 20
Shenyang 20
Tokyo 20
Nanchang 19
Houston 18
London 18
Marseille 18
Seattle 18
Changsha 17
Frankfurt am Main 17
Fremont 16
Montreal 16
The Dalles 16
Turku 16
Warsaw 16
Stockholm 15
Tianjin 15
Denver 13
Jakarta 13
Norwalk 13
Redmond 13
Brno 12
Jiaxing 12
Manchester 12
Mexico City 12
Nuremberg 12
Brooklyn 11
Rio de Janeiro 11
Seoul 11
Atlanta 10
Chennai 10
Modena 10
Ottawa 10
Reggio Emilia 10
Rome 10
Amsterdam 9
Can Tho 9
Hangzhou 9
Montegaldella 9
Poplar 9
Boston 8
Grafing 8
Orem 8
Vienna 8
Woodbridge 8
Zhengzhou 8
Amman 7
Ankara 7
Curitiba 7
Dhaka 7
Istanbul 7
Totale 7.682
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.690
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 252
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 244
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 241
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 225
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 213
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 206
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 200
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 197
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 195
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 193
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 190
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 189
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 177
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 176
Antitumoral effect of a nanotechnology-based photodynamic therapy. 176
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 174
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 167
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 167
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 167
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 166
Hake fish bone as a calcium source for efficient bone mineralization 165
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 165
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 162
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 162
Analgesic activity of new hybrid muscarinic agonists in mice 160
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 157
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 154
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 153
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 148
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 148
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 147
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 147
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 142
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 141
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 140
Brain Pharmacokinetics of Non-Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray-Mass Spectrometry and ex vivo Binding Study in Rats 139
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 139
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 139
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 137
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 133
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 129
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 126
Lithocholic acid competitively inhibitis EphA2-ephrinA1 binding: pharmacological and structural considerations. 125
Lithocholic acid competitively inhibits EphA2-ephrinA1 binding: pharmacological and structural considerations. 123
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 123
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 121
α7 Nicotinic Agonist AR-R17779 Protects Mice against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in a Spleen-Dependent Way 119
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation. 114
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines 110
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 109
Analgesic effects mediated by muscarinic ligands acting at both orthosteric and allosteric receptor binding sites 108
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 108
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 108
EphA2-ephrinA1 system in acute mesenteric inflammation due to ischemia-reperfusion in mice 107
Su1816–Protection by Ccr6 Blockade in a Murine Model of Crohn’s Disease 104
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 104
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 103
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis 102
Novel potent N-Methyl-d-Aspartate (NMDA) receptor antagonists or s1 receptor ligands based on properly substituted 1,4-dioxane ring 101
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 98
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors 95
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 90
New selective PDE4D inhibitors devoid of sedative effects in mice 88
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 83
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice 83
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2 73
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions 72
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors 39
Totale 11.610
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 0 56 19
2021/2022391 21 16 25 48 24 17 32 32 18 27 13 118
2022/20231.393 168 170 84 106 129 154 30 63 407 14 53 15
2023/2024656 23 54 12 29 43 143 67 36 24 37 70 118
2024/20251.765 84 87 114 124 188 196 74 68 188 152 161 329
2025/20265.321 417 624 1.510 418 598 234 415 161 536 306 102 0
Totale 11.610